Publications by authors named "L Mannent"

Claim this Profile
E
Efficacy and safety of rilzabrutinib in patients with moderate-to-severe atopic dermatitis: 16-week results from a proof-of-concept phase II clinical trial.
Leon Kircik, Athanasios Tsianakas, Fernando Valenzuela, Vincent Mikol, Gaowei Nian, Leda Mannent

Br J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rilzabrutinib in Antihistamine-Refractory Chronic Spontaneous Urticaria: The RILECSU Phase 2 Randomized Clinical Trial.
Ana Giménez-Arnau, Silvia Ferrucci, Moshe Ben-Shoshan, Vincent Mikol, Laurence Lucats, Leda Mannent

JAMA Dermatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab as an Adjunct to Oral Immunotherapy in Pediatric Patients With Peanut Allergy.
R Sharon Chinthrajah, Sayantani B Sindher, Kari C Nadeau, Jeffrey G Leflein, Jonathan M Spergel, Leda P Mannent

Allergy· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mild and symptom-free months in patients with chronic rhinosinusitis with nasal polyps treated with dupilumab.
Claus Bachert, Asif H Khan, Claire Hopkins, Joseph K Han, Wytske J Fokkens, Leda P Mannent

Ann Allergy Asthma Immunol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Dupilumab in Children With Peanut Allergy: A Multicenter, Open-Label, Phase II Study.
Sayantani B Sindher, Kari C Nadeau, R Sharon Chinthrajah, Jeffrey G Leflein, Philippe Bégin, Leda P Mannent

Allergy· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis